Collaboration Detail

I seek to establish a multidisciplinary research collaboration focused on advanced computational approaches for drug discovery and development. The collaboration will encompass various aspects of bioinformatics and computer-aided drug design, integrating modern computational tools with biological and pharmaceutical research. The proposed research activities include: Bioinformatics Analysis: Comprehensive analysis of genomic, proteomic, transcriptomic, and biological datasets to identify potential therapeutic targets and understand disease mechanisms. Molecular Docking Studies: Structure-based virtual screening and molecular docking to evaluate protein–ligand interactions, binding affinities, and potential drug candidates. Molecular Dynamics (MD) Simulations: Detailed assessment of protein–ligand complex stability, conformational flexibility, and interaction dynamics under physiological conditions. ADMET and Toxicity Prediction: In silico evaluation of absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiles to assess drug-likeness, pharmacokinetic behavior, and safety characteristics of lead compounds. QSAR Modelling: Development and validation of quantitative structure–activity relationship (QSAR) models for predicting biological activity and optimizing lead compounds through data-driven approaches. Perl Scripting and Computational Automation: Creation of customized Perl scripts and automated workflows for large-scale data processing, sequence analysis, virtual screening pipelines, and result interpretation. In addition to computational research support, the collaboration will provide comprehensive assistance throughout the scientific publication process. This includes study design, data analysis, result interpretation, graphical representation of findings, manuscript preparation, scientific editing, journal formatting, response to reviewer comments, and publication support in peer-reviewed international journals. The ultimate objective of this collaboration is to facilitate high-quality, reproducible, and impactful research outcomes by integrating computational biology, cheminformatics, and pharmaceutical sciences with strong scientific communication and publication expertise.